|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-6-6
|
|
pubmed:abstractText |
Fluorescence diagnosis induced by 5-aminolevulinic acid enables more thorough transurethral resection of superficial bladder carcinoma compared with conventional white light. We performed a prospective, single institution, randomized trial to investigate whether the residual tumor rate and long-term tumor recurrence can be decreased by fluorescence diagnosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
168
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12050494-Administration, Intravesical,
pubmed-meshheading:12050494-Adult,
pubmed-meshheading:12050494-Aged,
pubmed-meshheading:12050494-Aminolevulinic Acid,
pubmed-meshheading:12050494-Carcinoma, Transitional Cell,
pubmed-meshheading:12050494-Cystoscopy,
pubmed-meshheading:12050494-Disease-Free Survival,
pubmed-meshheading:12050494-Female,
pubmed-meshheading:12050494-Fluorescence,
pubmed-meshheading:12050494-Humans,
pubmed-meshheading:12050494-Male,
pubmed-meshheading:12050494-Middle Aged,
pubmed-meshheading:12050494-Neoplasm Staging,
pubmed-meshheading:12050494-Survival Rate,
pubmed-meshheading:12050494-Urinary Bladder Neoplasms
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
|
|
pubmed:affiliation |
Department of Urology, St. Joseph's Hospital and Institute of Pathology, University of Regensburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
